Translational biology of osteosarcoma, Nat Rev Cancer, vol.14, pp.722-735, 2014. ,
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.25, pp.113-123, 2014. ,
Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma, Curr Opin Oncol, vol.19, pp.341-346, 2007. ,
Metallothionein: the multipurpose protein, Cell Mol Life Sci, vol.59, pp.627-647, 2002. ,
Zinc Metabolism and Metallothioneins, Biol Trace Elem Res, vol.183, pp.22-31, 2018. ,
The roles of metallothioneins in carcinogenesis, J Hematol Oncol, vol.11, 2018. ,
Zinc chelation: a metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance, Cell Death Dis, vol.4, 2013. ,
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells, Nucleic Acids Res, vol.41, pp.955-961, 2013. ,
In-Vitro and In-Vivo Establishment and Characterization of Bioluminescent Orthotopic Chemotherapy-Resistant Human Osteosarcoma Models in NSG Mice, Cancers (Basel), vol.11, 2019. ,
SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients, Eur J Cancer, vol.43, pp.752-761, 2007. ,
Overview of tumor cell chemoresistance mechanisms, Methods Mol Med, vol.111, pp.127-148, 2005. ,
DHFR and MDR1 upregulation is associated with chemoresistance in osteosarcoma stem-like cells, Oncol Lett, vol.14, pp.171-179, 2017. ,
Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome, N Engl J Med, vol.333, pp.1380-1385, 1995. ,
P-glycoprotein expression: critical determinant in the response to osteosarcoma chemotherapy, J Natl Cancer Inst, vol.89, pp.1706-1715, 1997. ,
Analysis of P-glycoprotein expression in osteosarcoma, Eur J Cancer, vol.31, 1995. ,
Proteins expressed in osteosarcoma and serum levels as prognostic factors, Int J Biochem Cell Biol, vol.33, pp.11-17, 2001. ,
Overexpression of resistance-related proteins (metallothioneins, glutathione-S-transferase pi, heat shock protein 27, and lung resistance-related protein) in osteosarcoma. Relationship with poor prognosis, Cancer, vol.79, pp.2336-2344, 1997. ,
The ATP-dependent glutathione S-conjugate export pump, Trends Biochem Sci, vol.17, pp.463-468, 1992. ,
Glutathione Transferases: Potential Targets to Overcome Chemoresistance in Solid Tumors, Int J Mol Sci, vol.19, 2018. ,
Glutathione S-transferase polymorphisms in osteosarcoma patients, Pharmacogenet Genomics, vol.20, pp.507-515, 2010. ,
Reactions of glutathione with the catechol, the ortho-quinone and the semi-quinone free radical of etoposide. Consequences for DNA inactivation, Biochem Pharmacol, vol.43, pp.1761-1768, 1992. ,
Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione, Cancer Res, vol.57, pp.5238-5242, 1997. ,
Establishment, characterisation and partial cytokine expression profile of a new human osteosarcoma cell line (CAL 72), Int J Cancer, vol.82, pp.282-285, 1999. ,
Characterization of a new human osteosarcoma cell line OHS-4, J Cell Biol, vol.114, pp.577-583, 1991. ,
Comparison of HSCORE assessment of endometrial beta3 integrin subunit expression with digital HSCORE using computerized image analysis (ImageJ), Anal Quant Cytopathol Histpathol, vol.35, pp.210-216, 2013. ,